SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 49 filers reported holding SYROS PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $4,000 | -66.7% | 3,667 | 0.0% | 0.00% | – |
Q4 2021 | $12,000 | -25.0% | 3,667 | 0.0% | 0.00% | -100.0% |
Q3 2021 | $16,000 | -20.0% | 3,667 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $20,000 | -25.9% | 3,667 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $27,000 | -32.5% | 3,667 | 0.0% | 0.00% | -50.0% |
Q4 2020 | $40,000 | +25.0% | 3,667 | 0.0% | 0.00% | +100.0% |
Q3 2020 | $32,000 | -17.9% | 3,667 | 0.0% | 0.00% | -50.0% |
Q2 2020 | $39,000 | +160.0% | 3,667 | +40.9% | 0.00% | +100.0% |
Q1 2020 | $15,000 | -16.7% | 2,602 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $18,000 | -33.3% | 2,602 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $27,000 | +12.5% | 2,602 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $24,000 | 0.0% | 2,602 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $24,000 | +71.4% | 2,602 | 0.0% | 0.00% | 0.0% |
Q4 2018 | $14,000 | -54.8% | 2,602 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $31,000 | +14.8% | 2,602 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $27,000 | +92.9% | 2,602 | +137.0% | 0.00% | 0.0% |
Q1 2018 | $14,000 | +27.3% | 1,098 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $11,000 | -47.6% | 1,098 | 0.0% | 0.00% | 0.0% |
Q3 2017 | $21,000 | +16.7% | 1,098 | 0.0% | 0.00% | 0.0% |
Q2 2017 | $18,000 | +200.0% | 1,098 | +200.0% | 0.00% | – |
Q1 2017 | $6,000 | – | 366 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 3,439,895 | $18,747,000 | 4.66% |
Bain Capital Life Sciences Investors, LLC | 5,785,036 | $31,528,000 | 2.07% |
Omega Fund Management, LLC | 2,274,831 | $12,398,000 | 1.40% |
Altium Capital Management LP | 1,076,942 | $5,869,000 | 1.36% |
Samsara BioCapital, LLC | 2,189,199 | $10,599,000 | 1.31% |
Sio Capital Management, LLC | 800,000 | $4,360,000 | 1.08% |
Flagship Pioneering Inc. | 2,938,494 | $16,015,000 | 0.20% |
EcoR1 Capital, LLC | 1,000,000 | $5,450,000 | 0.20% |
Artal Group S.A. | 1,700,000 | $9,265,000 | 0.19% |
ACT CAPITAL MANAGEMENT, LLC | 52,500 | $287,000 | 0.15% |